Skip to main content

Natural history models of primary biliary cirrhosis

  • Chapter
Primary Biliary Cirrhosis
  • 81 Accesses

Abstract

The natural progression of primary biliary cirrhosis (PBC) has been modeled by a number of investigators based on Cox’s proportional hazards analysis1–3. The utility of these models is largely two-fold. On the one hand, these models have been used as a clinical tool in assessing prognosis with or without treatment. For example, the natural history model for PBC has been used in determining prognosis following transplantation, thereby assisting transplant physicians and surgeons in their decisions about patient selection and timing of transplantation4. On the other hand, these models are useful from the standpoint of clinical research. For instance, the prognostic indices of the models may be used as parameters of disease severity in risk stratification in clinical trials evaluating new treatment modalities5.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989:10:1–7.

    Article  PubMed  CAS  Google Scholar 

  2. Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptotic and symptomatic primary biliary cirrhosis. N Engl J Med 1983;308:1–7.

    Article  PubMed  CAS  Google Scholar 

  3. Christensen E, Neuberger J, Crowe J, et al. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis: final result of an international trial. Gastroenterology 1985;89:1084–91.

    PubMed  CAS  Google Scholar 

  4. Wiesner RH, Porayko MK, Dickson ER, et al. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1992;16:1290–9.

    Article  PubMed  CAS  Google Scholar 

  5. Lindor KD, Dickson ER, Baldus WP, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106:1284–90.

    PubMed  CAS  Google Scholar 

  6. Grambsch PM, Dickson ER, Kaplan M, LeSage G, Fleming TR, Langworthy AL. Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability. Hepatology 1989;10:846–50.

    Article  PubMed  CAS  Google Scholar 

  7. Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology 1996;24:1392–4.

    Article  PubMed  CAS  Google Scholar 

  8. Grambsch PM, Dickson ER, Wiesner RH, Langworthy A. Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients. Mayo Clin Proc 1989;64:699–704.

    PubMed  CAS  Google Scholar 

  9. Kim WR, Wiesner RH, Therneau TM, et al. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology (In press).

    Google Scholar 

  10. Poupon RE, Poupon R, Balkau B. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342–7.

    Article  PubMed  CAS  Google Scholar 

  11. Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 1996;110:1515–19.

    Article  PubMed  CAS  Google Scholar 

  12. Heathcote EJ, Lindor KD, Poupon R, et al. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884–90.

    Article  PubMed  Google Scholar 

  13. Kilmurry MR, Heathcote EJ, Cauch-Dudek K, et al. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? Hepatology 1996;23:1148–53.

    PubMed  CAS  Google Scholar 

  14. Lindor KD, Therneau TM, Hermans JE, Dickson ER. Mayo risk score accurately predicts patient outcome with ursodeoxycholic acid treatment of primary biliary cirrhosis [abstract]. Hepatology 1996;24:167A.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Kim, W.R., Dickson, E.R. (1998). Natural history models of primary biliary cirrhosis. In: Lindor, K.D., Heathcote, E.J., Poupon, R. (eds) Primary Biliary Cirrhosis. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4884-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4884-9_9

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6047-9

  • Online ISBN: 978-94-011-4884-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics